Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Pharmaceutical Sterility Testing (In-house, Outsourcing) Market 2018-2025 - ResearchAndMarkets.com

Research and Markets
Posted on: 01 Nov 18

The "Pharmaceutical Sterility Testing Market Size, Share & Trends Analysis Report By Type (In-house, Outsourcing), By Test Type, By End-use, By Sample (Sterile Drugs, Biologics & Therapeutics), And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical sterility testing market size is expected to reach USD 2.0 billion by 2025

The market is anticipated to expand at a healthy CAGR of 11.8% over the forecast period. Increasing number of drug launches coupled with the rising R&D expenditure across the globe is expected to be the key market growth drivers.

Technological advancements in sterility testing methods led to reduction of the procedural time and human intervention, thereby increasing the efficiency and accuracy of these tests. Latest advancements are flexible to suit the safety requirements of innovative products. The FDA also relaxed its regulatory requirements to allow the use of modern sterility tests for ensuring product safety.

Outsourcing of sterility testing is a strategy adopted by many companies in order to reduce cost. Moreover, several contract laboratories are available, which provide quality sterility testing at economic prices. Outsourcing of sterility testing also reduces the need for personnel training, equipment purchases, and manufacturing facility changes.

Regulatory framework for sterile products in pharmacies is increasingly becoming stringent owing to the several adverse events, such as meningitis outbreak (2012), associated with unsafe sterile products compounded in pharmacies. Moreover, the Drug Quality and Security Act provides the FDA authority to monitor and regulate the compounding of drugs, thereby, increasing adoption of sterility testing procedures by the compounding pharmacies.

Developing countries are harmonizing the regulatory framework with ICH standards and are also undertaking initiatives to boost the domestic production by providing incentives and tax concessions. Thus, developing nations are considered to be the future area for expansion of operations and outsourcing of sterility testing by multinational companies.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends & Scope

Chapter 4 Type Estimates & Trend Analysis

Chapter 5 Test-Type Estimates & Trend Analysis

Chapter 6 End-use Estimates & Trend Analysis

Chapter 7 Sample Estimates & Trend Analysis

Chapter 8 Regional Estimates & Trend Analysis, by Services

Chapter 9 Competitive Landscape

  • Pacific Biolabs
  • STERIS Corporation
  • Boston Analytical
  • Gibraltar Laboratories
  • Sartorius AG
  • Solvias AG
  • SGS SA
  • Toxikon, Inc
  • Pace Analytical Services LLC
  • Charles River Laboratories International, Inc
  • Thermo Fisher Scientific, Inc.
  • Nelson Laboratories, Inc.
  • Rapid Micro Biosystems, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/vrpptj/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005950/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.